SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-006560
Filing Date
2023-03-06
Accepted
2023-03-06 17:09:12
Documents
12
Period of Report
2023-03-02
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20230302.htm   iXBRL 8-K 34357
  Complete submission text file 0001628280-23-006560.txt   174120

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20230302.xsd EX-101.SCH 1893
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20230302_lab.xml EX-101.LAB 24831
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20230302_pre.xml EX-101.PRE 13037
6 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20230302_htm.xml XML 11254
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 23709844
SIC: 2834 Pharmaceutical Preparations